Related Experiment Video
Updated: May 30, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Tuberculosis in renal transplant recipients
Sibel Ersan1, Ali Celik, Koray Atila
1Division of Nephrology, Department of Internal Medicine, Dokuz Eylul University Hospital, Izmir, Turkey. sibel.ersan@deu.edu.tr
Renal transplant recipients have a 2.8% prevalence of tuberculosis (TB). Aggressive investigation and standard anti-TB therapy, including rifampicin, are crucial for successful treatment in these high-risk patients.
Area of Science:
- Nephrology
- Infectious Diseases
- Transplantation Immunology
Background:
- Renal transplant recipients are a high-risk group for Mycobacterium tuberculosis infection (tuberculosis, TB).
- Clinical presentations of TB in transplant patients can be atypical, necessitating thorough diagnostic approaches.
- Traditional diagnostic methods like tuberculin skin tests have limitations in patients with chronic renal failure.
Purpose of the Study:
- To determine the prevalence of tuberculosis (TB) in renal transplant recipients.
- To investigate the clinical manifestations of TB in this patient population.
- To evaluate patient and graft survivals following TB diagnosis and treatment.
Main Methods:
- A retrospective analysis of 320 pediatric and adult renal transplant recipients between 1992 and 2010.
- Data collected included TB prevalence, clinical presentations, immunosuppressive protocols, and survival outcomes.
- Review of treatment regimens and their efficacy.
Main Results:
- The prevalence of TB was found to be 2.8% among renal transplant recipients.
- Common symptoms included fever (77%), cough (66%), and abdominal pain (22%).
- Extrapulmonary TB occurred in five patients, affecting the intestines, pericardium, lymph nodes, and brain; one patient had both pulmonary and testicular involvement.
Conclusions:
- Tuberculosis affects 2.8% of renal transplant patients, highlighting the need for vigilance.
- A standard four-drug anti-TB regimen, including rifampicin, proved successful in most cases.
- Prompt diagnosis and treatment are essential for managing TB in this vulnerable population.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Kidney Transplant III: Nursing Management
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...